Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07565441 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Drug-Drug Interactions of JMKX003142 in Healthy Participants

StatusNot Yet Recruiting
PhasePhase 1
SponsorJemincare
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Jemincare
23 trials monitored
See all monitored trials
This is a single-center, non-randomized, open-label, self-controlled, Phase I clinical trial to evaluate the drug-drug interactions (DDI) of JMKX003142 tablets in healthy adult participants. The study consists of five cohorts (Cohorts 1, 2, 3, 4, and 5). A total of 24 participants are planned enrollment in each of Cohorts 1, 2, 3, and 5, while 16 participants are planned for Cohort 4.
Trial Details
NCT Number NCT07565441
Lead Sponsor Jemincare
Collaborators: Zhejiang Hangyu Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Related terms Polycystic Kidney, Autosomal Dominant
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov